UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia

Neuron (Cambridge, Mass.), 2017-07, Vol.95 (2), p.341-356.e6

2017

Volltextzugriff (PDF)

Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders

CNS drugs, 2019-10, Vol.33 (10), p.1001-1030

2019

Volltextzugriff (PDF)

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals

International journal of molecular sciences, 2020-12, Vol.22 (1), p.134

2020

Volltextzugriff (PDF)

Optical Intracranial Self-Stimulation (oICSS): A New Behavioral Model for Studying Drug Reward and Aversion in Rodents

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3455

2024

Volltextzugriff (PDF)

Cannabinoid CB₂ receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (46), p.E5007-E5015

2014

Volltextzugriff (PDF)

Cannabidiol inhibits sucrose self‐administration by CB1 and CB2 receptor mechanisms in rodents

Addiction biology, 2020-07, Vol.25 (4), p.e12783-n/a

2020

Volltextzugriff (PDF)

Cannabinoid CB 1 and CB 2 receptor mechanisms underlie cannabis reward and aversion in rats

British journal of pharmacology, 2019-05, Vol.176 (9), p.1268-1281

2019

Volltextzugriff (PDF)

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Scientific reports, 2017-12, Vol.7 (1), p.17410-17, Article 17410

2017

Volltextzugriff (PDF)

Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus

Neuron (Cambridge, Mass.), 2016-05, Vol.90 (4), p.795-809

2016

Volltextzugriff (PDF)

Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats

British journal of pharmacology, 2019-05, Vol.176 (9), p.1268-1281

2019

Volltextzugriff (PDF)

Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors

British journal of pharmacology, 2020-04, Vol.177 (8), p.1865-1880

2020

Volltextzugriff (PDF)

Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge

Cells (Basel, Switzerland), 2022-10, Vol.11 (20), p.3262

2022

Volltextzugriff (PDF)

β‐Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents

British journal of pharmacology, 2020-05, Vol.177 (9), p.2058-2072

2020

Volltextzugriff (PDF)

Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects

Neuropsychopharmacology (New York, N.Y.), 2019-07, Vol.44 (8), p.1415-1424

2019

Volltextzugriff (PDF)

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

Nature neuroscience, 2011-07, Vol.14 (9), p.1160-1166

2011

Volltextzugriff (PDF)

Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder

Neuropsychopharmacology (New York, N.Y.), 2021-03, Vol.46 (4), p.860-870

2021

Volltextzugriff (PDF)

(±)VK4‐40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents

British journal of pharmacology, 2020-10, Vol.177 (20), p.4796-4807

2020

Volltextzugriff (PDF)

Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats

Addiction biology, 2017-05, Vol.22 (3), p.752-765

2017

Volltextzugriff (PDF)

Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches

Molecular psychiatry, 2022-04, Vol.27 (4), p.2171-2181

2022

Volltextzugriff (PDF)

Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice

Addiction biology, 2021-07, Vol.26 (4), p.e13005-n/a

2021

Volltextzugriff (PDF)

Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals

Frontiers in neuroscience, 2022-01, Vol.15, p.811192-811192

2022

Volltextzugriff (PDF)

Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope

Proceedings of the National Academy of Sciences - PNAS, 2015-11, Vol.112 (47), p.E6562-E6570

2015

Volltextzugriff (PDF)

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders

Neuropsychopharmacology (New York, N.Y.), 2019-07, Vol.44 (8), p.1435-1444

2019

Volltextzugriff (PDF)

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist

Proceedings of the National Academy of Sciences - PNAS, 2018-11, Vol.115 (45), p.11597-11602

2018

Volltextzugriff (PDF)

Progress in brain cannabinoid CB2 receptor research: From genes to behavior

Neuroscience and biobehavioral reviews, 2019-03, Vol.98, p.208-220

2019

Volltextzugriff (PDF)

1 – 25 von 286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(258)

Publikationsform

Sprache

Englisch
(274)
Chinesisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia

Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals

Optical Intracranial Self-Stimulation (oICSS): A New Behavioral Model for Studying Drug Reward and Aversion in Rodents

Cannabinoid CB₂ receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Cannabidiol inhibits sucrose self‐administration by CB1 and CB2 receptor mechanisms in rodents

Cannabinoid CB 1 and CB 2 receptor mechanisms underlie cannabis reward and aversion in rats

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus

Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats

Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors

Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge

β‐Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents

Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder

(±)VK4‐40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents

Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats

Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches

Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice

Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals

Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist

Progress in brain cannabinoid CB2 receptor research: From genes to behavior

Suchergebnisse filtern